Physician profile
James C Brown
NPI 1659473486
$1,273.15
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,241 · 2020: $11.63 · 2021: $20.69.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $250.77 | 2019 | |
| Glaxosmithkline, LLC. | $219.69 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $216.89 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $123.49 | 2019 | |
| Novo Nordisk INC | $77.15 | 2019 | |
| Janssen Pharmaceuticals, INC | $71.75 | 2019-2020 | |
| Allergan, INC. | $51.20 | 2019 | |
| Pfizer INC. | $39.78 | 2019 | |
| Mylan Specialty L.P. | $37.64 | 2019 | |
| Merck Sharp & Dohme LLC | $37.40 | 2019 | |
| Novartis Pharmaceuticals Corporation | $27.82 | 2019 | |
| Medtronic Vascular, INC. | $26.57 | 2019 | |
| Sanofi Pasteur INC. | $24.95 | 2019 | |
| Amgen INC. | $21.81 | 2019 | |
| Abbvie INC. | $20.69 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $12.93 | 2019 | |
| Amarin Pharma, INC. | $12.62 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.